Delivery Order SPE2DB24D3013-SPE2DB24FFGXV
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $1,583.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML syringes. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,839.36 for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 12, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COPAXONE 40 MG/ML SYRINGEML. The contract has a ceiling value of $3,182.82 and a period of performance ending on May 7, 2025. It is a firm fixed-price contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE medicine. The award has a potential value of $4,842.48 and a completion date of February 16, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00, which serves as the primary contract vehicle for...
The U.S. government awarded a $4,072.90 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide COPAXONE 20 MG/ML SYRINGEML. This contract was issued by the Defense Logistics Agency Troop Support Medical, which is a defense agency responsible for medical supply chain management. The contract has an ultimate completion date of January 2, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $1,638 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COPAXONE 40 MG/ML syringes, which are used to treat multiple sclerosis. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This federal contract award, valued at $4,306.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of July 23, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $1,092.00 and a completion date of April 2, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,176.33 firm fixed-price contract is for the supply of COPAXONE 40 MG/ML syringes, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of May 5, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of COPAXONE 40 MG/ML SYRINGEML. The firm-fixed-price delivery order contract has a ceiling value of $2,122.56 and a completion date of June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...